l carnitine oral bioavailability L-carnitine modified nanoparticles target the OCTN2 transporter to improve the oral oral l carnitine bioavailability Enhanced

The peptide demonstrates ability to reduce production of pro-inflammatory cytokines including tumor necrosis factor-alpha (TNF-) and interleukin-1 beta (IL-1), while promoting anti-inflammatory responses

Glutathione S-transferase (GST) as the target enzyme because GSTs are key detoxification proteins that conjugate glutathione to xenobiotics and reactive intermediates, thereby protecting bacteria from oxidative damage and chemical stress

J., Eun, H

This third pathway increases energy expenditure independent of appetite suppression

Lysine and methionine are limiting amino acid, which means they are most likely to be deficient relative to the horses requirements